LCLA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kalbe Farma Tbk PT

Watchlist Manager

Watchlist

Price: 0.0295 EUR -29.76%

Market Cap: €1.4B

K	Kalbe Farma Tbk PT SWB:LCLA	ID
	Farmacias Benavides SAB de CV BMV:BEVIDESB	MX
H	HB Fuller Co F:HB1	US
	Clinica Baviera SA F:D9Z	ES
	Yangtze Optical Fibre and Cable Joint Stock Ltd Co HKEX:6869	CN
	Ascentech KK TSE:3565	JP
D	Daishin Securities Co Ltd KRX:003540	KR

Profitability Summary

Kalbe Farma Tbk PT's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Sustainable 3Y Average Gross Margin

38%

Declining Gross Margin

38% > 37%

Healthy Operating Margin

12%

Sustainable 3Y Average Operating Margin

12%

Declining Operating Margin

12% > 12%

Low Net Margin

10%

Low 3Y Average Net Margin

10%

Declining Net Margin

10% > 10%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

4% > 6%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

ROIC is Increasing

14% > 15%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.